Clinical Trial Update: Long-term Safety and Tolerability of AFFITOPE AD02

View source ↗

Summary

A long-term safety and tolerability update of the Alzheimer's disease vaccine candidate AFFITOPE AD02 from Affiris AG has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AFFITOPE AD02 (AD02)

Snippet

Sponsor: Affiris AG | Conditions: Alzheimer's Disease | Status: COMPLETED